ArticleMethods in molecular biology (Clifton, N.J.)2025
Identification of Anticancer ROS Targets by Cysteine Reactivity Protein Profiling.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cysteine reactivity profiling is recognized as a powerful and versatile chemoproteomic technology to study the cysteinome in native biological systems. It involves the use of chemical probes that covalently bind to reactive cysteines, enabling the enrichment and quantitively analysis of cysteine abundance through mass spectrometry. Cysteines play critical roles in maintaining cellular redox homeostasis by dynamically switching between their reduced and oxidized forms during redox perturbations. Here, we described a detailed workflow of sample preparation for cysteine-based chemical proteomics, to systematically identify cysteines that are modified by anticancer drug induced ROS.
Indexed as
Identifiers
40515995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.